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In vitro antibacterial activity of raw and commercially available honey was tested against Gram-positive 
bacteria (Staphylococcus aureus) and Gram-negative bacteria (Escherichia coli, Pseudomonas 
aeruginosa, Shigella spp. and Salmonella spp.). Both types of honey showed antibacterial activity 
against test organisms with the zone of inhibition ranging from 8.13 to 30.85 mm, while E. coli, S. 
aureus, and Shigella spp. showed sensibility towards both types of honey. Raw honey possesses more 
inhibitory activity against S. aureus and Shigella spp., than commercially available honey. On the other 
hand, commercially available honey possesses more inhibitory activity than raw honey against E. coli. 
Both types of honey showed no effects on Salmonella spp. The potency of honey at 100% 
concentration was found to be higher than all other concentrations tested. However, no effect was 
observed at concentration of 6.25% v/v honey in the case of both samples. 
 






Honey is a popular sweetener and a common household 
product throughout the world. It is nonirritant, nontoxic, 
available and cheap (Bansal et al., 2005). It has been 
used from ancient times as a method of accelerating 
wound healing (Van den Berg et al., 2008; Mullai and 
Menon, 2007). Traditional importance and use of honey 
as therapeutics has been mentioned by the Egyptian and 
Sumerian physicians as early as 4000 years ago 
(Maryann, 2000). Ibne Sina, the Prince among Muslim 
physicians listed several beneficial uses of honey in his 
monumental work of “The Canon of Medicine” and 
Hippocrates, the father of Western Medicine, used honey 
to treat a number of diseases (Khalil et al., 2006). Ancient 
users did not know its antibacterial properties; they only 
knew it as an effective remedy. During the twentieth 
century, it was reported that honey have good 
antimicrobial properties together with therapeutic 
potential in wound healing (Medhi et al., 2008; Pieper and 
Caliri, 2003; Moore et al., 2001). Various studies have 
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Patton et al., 2006).  
It has been shown that natural unheated honey has 
some broad-spectrum antibacterial activities when tested 
against pathogenic bacteria, oral bacteria as well as food 
spoilage bacteria (Mundo et al., 2004). On the other 
hand, bacteria are not uniformly affected by honey. 
Furthermore, it has been shown that different honeys 
vary substantially in the potency of their antibacterial 
activity, which varies with the plant source (Wilkinson and 
Cavanagh, 2005). 
Since both raw honey and commercially available 
honey is used extensively in Bangladesh, the purpose of 
the present study was to evaluate in vitro antibacterial 
activity of these two types of honey against five human 
pathogenic bacterial cultures such as Staphylococcus 
aureus, Escherichia coli, Pseudomonas aeruginosa, 








Two kinds of honeys were used in this study.  They  are  raw  honey 




and commercially available honey. Raw honey was collected from 
the comb and commercially available honey was bought from the 
market. The samples were kept in the dark at room temperature. 
Sterility of honey was checked by spreading a loopful quantity on 





Five species of bacteria which are pathogenic to human were 
collected from The General Hospital of Kushtia city. They include 
Gram negative P. aeruginosa, E. coli, Salmonella spp., Shigella 
spp. and Gram positive S. aureus. These bacteria were isolated 
from the infected individuals’ urine, stool and pus samples and 
identified by standard methods (Harley and Prescott, 2002). Pure 
cultures of isolates were preserved at 4°C on nutrient agar slants. 
In order to confirm the identity of the test bacterial isolates, 
morphological characteristics and conventional biochemical tests 
were performed according to Harley and Prescott (2002). 
 
 
Susceptibility test  
 
The antibacterial susceptibility was determined by Kirby and Bauer 
disk diffusion method in accordance with the Clinical and 
Laboratory Standards Institute Guidelines using commercially 
available antimicrobial discs. The following antibiotics were used: 
Amoxicillin (10 µg), tetracycline (10 µg), chloromphenicol (30 µg), 
streptomycin (5 µg) and Kanamycin (30 µg).  
 
 
Determination of minimum inhibitory concentration (MIC) 
 
The MIC was determined as described by Mulu et al. (2004). 
Mueller Hinton Agar (Merck) was sterilized and held in a water bath 
(45 to 50°C). Honeys were briefly heated to 40°C to reduce 
viscosity and known volumes of honey were measured into 20 ml of 
molten media to give final concentrations of 100, 75, 50, 25, 12.5 
and 6.25% (v/v). The plates were poured, allowed to set and 
seeded with bacteria adjusted at 1 × 104 CFU/ ml before incubation 
at 37°C for 24 h. The MIC was recorded as the lowest 
concentration of honey at which visible bacterial growth was 
completely inhibited. This experiment was performed in triplicate to 





The results of the antibacterial activity assays indicated 
that both types of honey have inhibitory activity against E. 
coli, S. aureus and Shigella spp. On the other hand, P. 
aeruginosa is only susceptible to commercially available 
honey. However, no inhibitory activity was observed 
against Salmonella spp. Mean results of antibacterial 
activity assays are represented in Table 1. 
Raw honey possesses more inhibitory activity against 
S. aureus and Shigella spp., than commercially available 
honey. On the other hand, commercially available honey 
possesses more inhibitory activity than raw honey against 
E. coli. However, both honeys showed no inhibitory 
activity on Salmonella spp. Table 1 also shows that 
Shigella spp. and P. aeruginosa showed multiple drug 
resistance pattern and these two microbes are 
susceptible to commercially available honey.  





Table 2. The mean MIC of raw honey was recorded as 
12.5% (v/v) against S. aureus and Shigella spp. and 
commercially available honey as 25% (v/v) against 
Shigella spp. (Table 2). The potency of honey at 100% 
concentration was found to be higher than all other 
concentrations tested. However, no effect was observed 
at concentration of 6.25% v/v honey in the case of both 





In general, all types of honey have high sugar content as 
well as low water content and acidity, which prevent 
microbial growth. Osmotic effect, effect of pH and 
hydrogen peroxide are represented as an “inhibition” 
factor in honey (Postmes et al., 1993). Most types of 
honey generate hydrogen peroxide when diluted because 
of the activation of the enzyme glucose oxidase, which 
oxidizes glucose to gluconic acid and hydrogen peroxide 
(Schepartz and Subers, 1964). Hydrogen peroxide is the 
major contributor to the antimicrobial activity of honey, 
and the different concentrations of this compound in 
different honeys result in their variable antimicrobial 
effects (Molan, 1992). Moreover, nonperoxide factors 
also play critical role. The content of nonperoxide factors 
are related to the floral source and sometimes account 
for the major part of the antibacterial activity in honey 
(Molan and Russell, 1988). Besides its antimicrobial 
properties, honey can clear infection in a number of 
ways, including boosting the immune system, having anti-
inflammatory and antioxidant activities, and via 
stimulation of cell growth (Al-Jabri, 2005). 
The Tables 1 and 2 show the results of in vitro sus-
ceptibility and minimum inhibitory concentration of raw 
and commercially available honey having varying degree 
of antibacterial activities against Gram-positive as well as 
Gram-negative bacteria. Our results resembles that of 
others (El-Amari and Ben-Gweirif, 2010; Mulu et al., 
2004; Cooper et al., 1999, 2002; French et al., 2005; 
Nzeako and Hamdi, 2000; Agbaje et al., 2006; Basson 
and Grobler, 2008) who found that honey inhibited the 
growth of S. aureus, E. coli, Shigella spp. and 
Pseudomonas sp. and 100% concentrated honey is more 
effective than other concentrations (El-Amari and Ben-
Gweirif, 2010). In the case of Shigella spp., our results 
differ from the result of other researchers (Mulu et al., 
2004).  
Our results also showed that the test organisms 
exhibited varying degrees of multidrug resistance to 
standard antibiotics, which were used in this study. 
However, when honey was administered, they show 
susceptibility. These findings resemble the previous 





The present  study  showed  that  certain  organisms  are 




Table 1. Antibacterial susceptibility of raw and commercially available honey. 
 
Test organism 
Raw honey Commercially available honey A10 T10 CiP30 Stp5 Kn30 
Zone of inhibition (mm) 
Escherichia coli 8.13 ± 1.7 23.85± 0.9 16.67 ± 2.2 15.07 ± 1.2 17.14 ±3 15.21 ± 1.8 12.07 ±4 
S. aureus 30.85 ±3 20.01 ± 6.1 14.75 ± 1.7 12.09 ±9 16.67 ± 3.5 15.11 ± 1.6 14.65 ± 1.8 
Salmonella spp. - - 7.25 ± 2.3 7.28 ± 4.3 8.35±1.9 6.27 ± 3.3 - 
Shigella spp. 20.60 ± 13.5 13.19 ±9 14.20 ±9 - 13.10 ± 1.3 17.15 ±4 - 
P. aeruginosa - 10.13 ± 0.41 9.32±1.5 10.03 ± 0.51 16.01 ± 0.81 - - 
 
A10 = Amoxicillin (10 µg), T10 = tetracycline (10 µg), CiP30 = chloromphenicol (30µg), Stp5 = streptomycin (5 µg), Kn30 = kanamycin (30 µg) and “-“ = no 




Table 2. Minimum inhibitory concentration of raw and commercially available honey. 
 
Test organism 
Mean of inhibition zone (diameter in mm) 
Raw honey  Commercially available honey 
Concentration (v/v %) 
100 75 50 25 12.5 6.25  100 75 50 25 12.5 6.25 
S. aureus 30±0.0 20±0.0 19±0.0 6±0.0 5±0.0 -  20±0.0 23±0.0 - - - - 
E. coli 8±0.5 6±0.0 5±0.5 - - -  23±0.0 15±0.0 7±0.5 - - - 
Shigella spp. 20±0.0 8±0.0 7±0.0 7±0.0 6±0.5 -  13±0.0 8±0.0 6±0.0 6±0.0 - - 
P. aeruginosa - - - - - -  10±0.5 8±0.0 - - - - 
Salmonella spp. - - - - - -  - - - - - - 
 




sensitive to honey and honey can be used as alternative 
therapy against certain bacteria. Therefore, it is neces-
sary to characterize the active antimicrobial components 
of honey. In addition, more investigation is needed to 
explore the possible benefits of the use of honey among 
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